PhaseBio Pharmaceuticals OverviewPhaseBio Pharmaceuticals Operating Income
Operating Income for PHAS.
Quarterly Operating Income
$-16549000.00
↓ 21.39% YoY
As of Jun 30, 2022
Annual Operating Income (TTM)
$29.35M
↓ 131.5% YoY
Trailing 12 months ending Jun 30, 2022